Evidence Library

Filter by drug, type, year, and open access.

Drug

Type

Year ≥

Sort

Open access

Active filters:Drug: aripiprazole-asimtufii ×Clear filters

Showing 1–2 of 2 results

Pharmacokinetic evaluation of aripiprazole monohydrate as a once every 2-months long-acting injectable antipsychotic for schizophrenia — Expert Opinion on Drug Metabolism & Toxicology (2025)• Drug: aripiprazole-asimtufiiDOI PMID
Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii) in people with bipolar I disorder: a plain language summary — Therapeutic Advances in Psychopharmacology (2024)• Drug: aripiprazole-asimtufiiOpen accessDOI PMID PMCID

PsychMed Evidence Library — Guidelines, Trials, Meta-Analyses